351 related articles for article (PubMed ID: 26875957)
21. Clinical Characteristics and Prognosis of Multiple Myeloma With Myelomatous Pleural Effusion: A Retrospective Single-Center Study.
Gao L; Xu J; Xie W; Wang B; Cen X; Wang M
Technol Cancer Res Treat; 2022; 21():15330338221132370. PubMed ID: 36254566
[No Abstract] [Full Text] [Related]
22. Recurrent pleural effusion in myeloma.
Woo WH; Ithnin A; Raffali MAAM; Abd Hamid MF; Abdul Wahid SF; Wan Jamaludin WF
Oxf Med Case Reports; 2022 Aug; 2022(8):omac091. PubMed ID: 35991502
[TBL] [Abstract][Full Text] [Related]
23. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
Choi H; Ko Y; Lee CY
BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
[TBL] [Abstract][Full Text] [Related]
24. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
[TBL] [Abstract][Full Text] [Related]
25. [The diagnostic value of medical thoracoscopy for unexplained pleural effusion].
Jiang SJ; Mu XY; Zhang S; Su LL; Ma WX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):337-40. PubMed ID: 24047806
[TBL] [Abstract][Full Text] [Related]
26. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Biaoxue R; Min L; Tian F; Wenlong G; Hua L
BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
[TBL] [Abstract][Full Text] [Related]
27. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
[TBL] [Abstract][Full Text] [Related]
28. Pleural effusion and multiple myeloma - more than meets the eye: A case report.
Ramos AL; Trindade M; Santos Pinto A; Brandão JR; Pedrosa C; Pinto A
Mol Clin Oncol; 2021 Nov; 15(5):238. PubMed ID: 34650805
[TBL] [Abstract][Full Text] [Related]
29. [Billateral pleural effusion as first manifestation of multiple myeloma].
Radić-Kristo D; Kolonić SO; Kardum-Skelin I; Rogulj IM; Vrhovac R; Planinc-Peraica A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():207-11. PubMed ID: 23126054
[TBL] [Abstract][Full Text] [Related]
30. Flow Cytometry in Diagnosis of Myelomatous Pleural Effusion: A Case Report.
Arora P; Gupta SK; Mallik N; Mittal R; Sharma OD; Kumar L
Indian J Hematol Blood Transfus; 2016 Jun; 32(Suppl 1):138-42. PubMed ID: 27408376
[TBL] [Abstract][Full Text] [Related]
31. Myelomatous pleural effusion.
Ghosh S; Gopal R; Advani SH
J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
[TBL] [Abstract][Full Text] [Related]
32. Unilateral pleural effusion as a presenting manifestation of plasma cell myeloma (multiple myeloma): a case report.
Dharan M
Acta Cytol; 2010; 54(5 Suppl):780-2. PubMed ID: 21053539
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of soluble B7-H4 and carcinoembryonic antigen in distinguishing malignant from benign pleural effusion.
Jing X; Wei F; Li J; Dai L; Wang X; Jia L; Wang H; An L; Yang Y; Zhang G; Cheng Z
Clin Respir J; 2018 Mar; 12(3):986-990. PubMed ID: 28127951
[TBL] [Abstract][Full Text] [Related]
34. Myelomatous Pleural Effusion: Thoracoscopic Findings.
Nakashima K; Demura Y; Ishizuka T
Intern Med; 2024 Jun; 63(11):1667. PubMed ID: 37866914
[No Abstract] [Full Text] [Related]
35. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.
Hsu LH; Hsu PC; Liao TL; Feng AC; Chu NM; Kao SH
BMC Cancer; 2016 Jul; 16():463. PubMed ID: 27411914
[TBL] [Abstract][Full Text] [Related]
36. Myelomatous pleural effusion: report of an unusual occurrence.
Brabeck MC; Bubly G; Hunter TJ; Griffith RC
R I Med J (1976); 1990 Oct; 73(10):487-9. PubMed ID: 2263845
[TBL] [Abstract][Full Text] [Related]
37. Myelomatous Pleural Effusion: A Rare Involvement in Myeloma.
Alkan O; Tiryaki TO; Kalayoglu-Besisik S
J Med Cases; 2020 Mar; 11(3):55-56. PubMed ID: 34434362
[TBL] [Abstract][Full Text] [Related]
38. The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa.
Koegelenberg CFN; Bennji SM; Boer E; Schubert PT; Shaw JA; Allwood BW; Irusen EM
S Afr Med J; 2018 Mar; 108(4):275-277. PubMed ID: 29629675
[TBL] [Abstract][Full Text] [Related]
39. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).
Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW
Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157
[No Abstract] [Full Text] [Related]
40. [The usefulness of pleural biopsy in benign or malignant pleurisy].
Inoue Y; Miura N; Watanabe T; Watanabe K; Tsutsumi T; Doutsu Y; Kohno S; Kanda T; Hirota M; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):332-7. PubMed ID: 2067153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
